A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2017-12-04
- Lead Sponsor
- Celgene
- Target Recruit Count
- 624
- Registration Number
- NCT02556905
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of
🇰🇷Soon Chun Hyang University Hospital Bucheon, Bucheon, Korea, Republic of
Abraxane in Treatment of Metastatic Breast Cancer
- First Posted Date
- 2015-09-21
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Celgene
- Target Recruit Count
- 203
- Registration Number
- NCT02555696
- Locations
- 🇦🇹
Medical University Innsbruck, Innsbruck, Austria
🇦🇹LKH Salzburg, Salzburg, Austria
🇦🇹KH SMZ Ost, Vienna, Austria
ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- Celgene
- Target Recruit Count
- 20
- Registration Number
- NCT02551185
- Locations
- 🇺🇸
Pinnacle Oncology Hematology, Scottsdale, Arizona, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Celgene
- Target Recruit Count
- 100
- Registration Number
- NCT02546986
- Locations
- 🇺🇸
Palo Verde Hematology Oncology, Glendale, Arizona, United States
🇺🇸UCLA Hematology Oncology, Los Angeles, California, United States
🇺🇸University Cancer and Blood Center, LLC, Athens, Georgia, United States
A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Celgene
- Target Recruit Count
- 17
- Registration Number
- NCT02538965
- Locations
- 🇺🇸
Children's Hospital, Birmingham, Alabama, United States
🇺🇸Miller Children's Hospital, Long Beach, California, United States
🇺🇸Children's Hospital of Los Angeles, Los Angeles, California, United States
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
- First Posted Date
- 2015-08-24
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Celgene
- Target Recruit Count
- 878
- Registration Number
- NCT02531126
- Locations
- 🇺🇸
Local Institution - 102, Anaheim, California, United States
🇺🇸Local Institution - 179, Germantown, Tennessee, United States
🇺🇸Local Institution - 143, Portland, Oregon, United States
Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease
- First Posted Date
- 2015-08-24
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Celgene
- Target Recruit Count
- 69
- Registration Number
- NCT02531113
- Locations
- 🇨🇦
LHSC Victoria Hospital, London, Ontario, Canada
🇺🇸IMIC, Inc., Palmetto Bay, Florida, United States
🇺🇸DM Clinical Research, Oak Lawn, Illinois, United States
An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide.
- Conditions
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Celgene
- Target Recruit Count
- 238
- Registration Number
- NCT02528838
Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Celgene
- Target Recruit Count
- 28
- Registration Number
- NCT02521714
- Locations
- 🇺🇸
Covance-Daytona Beach, Daytona Beach, Florida, United States
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
- First Posted Date
- 2015-07-29
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Celgene
- Target Recruit Count
- 16
- Registration Number
- NCT02510937
- Locations
- 🇺🇸
LaPorte County Institute for Clinical Research, Inc, Michigan City, Indiana, United States
🇺🇸Tampa General Hospital, Tampa, Florida, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States